COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,646 Articles (22,459 medRxiv, 8,187 bioRxiv)

Most recent first Previous |  Page 620: Articles 6191-6200  | Next

UVC-based air disinfection system for rapid inactivation of SARS-CoV-2 present in the air
Garg, H., Ringe, R. P., Das, S., Parkash, S., Thakur, B., Delipan, R., Kumar, A., Kulkarni, K. S., Bansal, K., Patil, P. B., Alam, T., Balam, N. B., Meena, C. S., Thakur, K. G., Kumar, A., Kumar, A.
10.1101/2022.08.02.502427 — Posted: 2022-08-02
Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5
Muik, A., Lui, B. G., Bacher, M., Wallisch, A.-K., Toker, A., Finlayson, A., Krueger, K., Ozhelvaci, O., Grikscheit, K., Hoehl, S., Ciesek, S., Tuereci, O., Sahin, U.
10.1101/2022.08.02.502461 — Posted: 2022-08-02
NF-κB inhibitor alpha has a cross-variant role during SARS-CoV-2 infection in ACE2-overexpressing human airway organoids
Simoneau, C. R., Chen, P.-Y., Xing, G. X., Khalid, M. M., Meyers, N. L., Hayashi, J. M., Taha, T. Y., Leon, K. E., Ashuach, T., Fontaine, K. A., Rodriguez, L., Joehnk, B., Walcott, K., Vasudevan, S., Fang, X., Maishan, M., Schultz, S., Roose, J., Matthay, M. A., Sil, A., Arjomandi, M., Yosef, N., Ott, M.
10.1101/2022.08.02.502100 — Posted: 2022-08-02
Serological surveillance for wild rodent infection with SARS-CoV-2 in Europe
Bourret, V., Dutra, L., Alburkat, H., Maki, S., Lintunen, E., Wasniewski, M., Kant, R., Grzybek, M., Venkat, V., Asad, H., Pradel, J., Bouilloud, M., Leirs, H., Colombo, V. C., Sluydts, V., Stuart, P., McManus, A., Eccard, J. A., Firozpoor, J., Imholt, C., Nowicka, J., Goll, A., Ranc, N., Castel, G., Charbonnel, N., Sironen, T.
10.1101/2022.08.02.502439 — Posted: 2022-08-02
SARS-CoV-2 Omicron BA.1 and BA.2 are attenuated in rhesus macaques as compared to Delta
van Doremalen, N., Singh, M., Saturday, T., Yinda, K. C., Perez-Perez, L., Bohler, W. F., Weishampel, Z., Lewis, M., Schulz, J., Williamson, B., Meade-White, K., Gallogly, S., Okumura, A., Feldmann, F., Lovaglio, J., Hanley, P., Shaia, C., Feldmann, H., de Wit, E., Munster, V., Rosenke, K.
10.1101/2022.08.01.502390 — Posted: 2022-08-02
Does Influenza vaccination reduce the risk of contracting COVID-19?
Alos, F., Canovas-Zaldua, Y., Feijoo, M. V., del val, J. L., Sanchez-Callejas, A., Colomer, M. A.
10.1101/2022.08.01.22278264 — Posted: 2022-08-02
The speed of vaccination rollout and the risk of pathogen adaptation
Gandon, S., Day, T., Lambert, A.
10.1101/2022.08.01.22278283 — Posted: 2022-08-02
Complex Temporal Behaviour Modeling for Pandemic Spread: Not a Simple Delayed Response!
Shahtori, N., Atashzar, S. F.
10.1101/2022.08.01.22278281 — Posted: 2022-08-02
Intermediate levels of asymptomatic transmission can lead to the highest levels of epidemic fatalities
Park, S. W., Dushoff, J., Grenfell, B., Weitz, J. S.
10.1101/2022.08.01.22278288 — Posted: 2022-08-02
Viral and Symptom Rebound in Untreated COVID-19 Infection
Deo, R., Choudhary, M. C., Moser, C., Ritz, J., Daar, E. S., Wohl, D. A., Greninger, A. L., Eron, J. J., Currier, J. S., Hughes, M. D., Smith, D. M., Chew, K. W., Li, J. Z.
10.1101/2022.08.01.22278278 — Posted: 2022-08-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).